Ortho

Aurora Spine Corporation Announces First Quarter Fiscal 2023 Financial Results

Retrieved on: 
Wednesday, May 24, 2023

CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023. All figures are in U.S. dollars.

Key Points: 
  • CARLSBAD, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its first quarter fiscal 2023 ended March 31, 2023.
  • SiLO TFX – Initial surgeries using the SiLO TFX device occurred in March 2023 with a larger release scheduled in Q3 2023.
  • Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, “First quarter was a transitional quarter for Aurora, where the industry had to manage certain reimbursement changes that affected our SI joint division.
  • Total operating expenses were $2.191 million for the first quarter of 2023, compared to $2.288 million in the first quarter of 2022.

Cheer Pack North America (Cheer Pack NA) and ScottsMiracle-Gro Introduce a New Flexible Packaging Design for Weed Control Concentrates

Retrieved on: 
Tuesday, April 11, 2023

WEST BRIDGEWATER, Mass., April 11, 2023  /PRNewswire-PRWeb/ -- The Flexible 5-oz Spouted Pouches Reduce Material Waste and Feature Child-Resistant Caps

Key Points: 
  • Cheer Pack North America (Cheer Pack NA) developed a new flexible packaging solution for ScottsMiracle-Gro's Ortho GroundClear weed and grass killer concentrate.
  • Inspired by refillable and reusable packaging innovations in other industries, ScottsMiracle-Gro teamed up with Cheer Pack NA to develop 5-oz flexible spouted pouches that are the first of their kind in the weed control category.
  • Cheer Pack North America (Cheer Pack NA) developed a new flexible packaging solution for ScottsMiracle-Gro's Ortho GroundClear weed and grass killer concentrate.
  • Cheer Pack NA has designed and manufactured a wide variety of flexible packaging solutions over many markets.

Therapeutic Articulations Launches Innovative Orthopedic Device

Retrieved on: 
Wednesday, April 5, 2023

It is my hope that clinicians will use the Mobil-Aider to enhance the quality of orthopedic care," said Dr.

Key Points: 
  • It is my hope that clinicians will use the Mobil-Aider to enhance the quality of orthopedic care," said Dr.
  • Dawn Gulick, Founder and CEO of Therapeutic Articulations, a Chester County start-up.
  • With over 7.2 million orthopedic injuries each year, the Mobil-Aider is poised to be the gold standard for joint assessment.
  • The Mobil-Aider is an FDA-cleared, patent-pending (Notice of Allowance received) device that has the versatility to be used on multiple joints.

Ortho sets new bars with the STARLIGHT phygital fashion initiative

Retrieved on: 
Wednesday, March 29, 2023

Ortho, a phygital universe of fashion, opens up novel ways for people to express their style and identity in the digital realm.

Key Points: 
  • Ortho, a phygital universe of fashion, opens up novel ways for people to express their style and identity in the digital realm.
  • With the successful introduction of its digital fashion open-metaverse and a sensational Le Thanh Hoa's runway show, Ortho continues to strive for its ambition to become a place where imagination and creativity reign supreme with the first-ever phygital fashion item called STARLIGHT.
  • STARLIGHT sweater is the latest offering in Ortho's range of phygital fashion items, allowing consumers to select their favorite NFT from their own collection to be embroidered and personalized on the sweater.
  • With Starlight, Ortho reaffirms its vanguard of fashion innovation, empowering customers to express their individuality through a unique blend of fashion and technology.

QuidelOrtho Reports Fourth Quarter and Full Year 2022 Financial Results

Retrieved on: 
Wednesday, February 15, 2023

GAAP diluted earnings per share (EPS) for the fourth quarter of 2022 decreased to $0.45, compared to $6.85 for the fourth quarter of 2021.

Key Points: 
  • GAAP diluted earnings per share (EPS) for the fourth quarter of 2022 decreased to $0.45, compared to $6.85 for the fourth quarter of 2021.
  • GAAP operating income for the fourth quarter of 2022 was $86.5 million, compared to $376.7 million for the fourth quarter of 2021, and GAAP operating margin was 10% and 59% for the fourth quarters of 2022 and 2021, respectively.
  • Adjusted diluted EPS for the fourth quarter of 2022 decreased to $1.76, compared to $5.12 for the fourth quarter of 2021.
  • Adjusted EBITDA margin for the fourth quarter of 2022 was 28.3%, compared to 45.6% for the fourth quarter of 2021.

Benevis Introduces Ortho Calculator for Effective Family Budgeting

Retrieved on: 
Tuesday, January 31, 2023

The ortho calculator will be featured across all 20 of their affiliated dental brand’s websites to serve their community members better.

Key Points: 
  • The ortho calculator will be featured across all 20 of their affiliated dental brand’s websites to serve their community members better.
  • Our ortho calculator will help parents understand the financial aspect of getting their child the orthodontic care they need,” said Carl Helton, ortho program director at Benevis.
  • “Whether the patient has insurance, is covered under Medicaid, or is paying out-of-pocket, the ortho calculator will help patients and families understand the terms of their payment plan.”
    Benevis' ortho calculator was designed to provide pricing transparency and payment options to help break down barriers to dental care.
  • The ortho calculator payment tool is provided to estimate a potential monthly cost of orthodontic treatment and is offered to the user "as-is."

Vexcel Data Program to Enhance and Refresh its U.S. Aerial Imagery Program in 2023

Retrieved on: 
Monday, February 13, 2023

It plans to collect 4.5 million km2 of high-resolution aerial imagery in 2023, covering 93% of the U.S. population

Key Points: 
  • It plans to collect 4.5 million km2 of high-resolution aerial imagery in 2023, covering 93% of the U.S. population
    CENTENNIAL, Colo., Feb. 13, 2023 /PRNewswire/ -- Vexcel Data Program , the world's largest aerial imagery program, announced today it will expand its high-resolution coverage in urban areas and refresh its current aerial imagery collection in the United States.
  • Vexcel to collect 4.5 million km2 of high-resolution aerial imagery in 2023, covering 93% of the U.S. population.
  • "We've already been the largest provider of aerial imagery in the U.S., and now we're enhancing our collection with more ortho aerial imagery at 7.5cm resolution.
  • Vexcel has the largest annual aerial imagery collection in the U.S., up to 5 times more coverage than its competition.

GaitBetter announces Category III CPT® add-on code for motor-cognitive, semi-immersive virtual reality-facilitated gait training

Retrieved on: 
Thursday, February 2, 2023

ROCKVILLE, Md., Feb. 2, 2023 /PRNewswire-PRWeb/ -- GaitBetter, a digital neurotherapeutics company providing a state-of-the-art motor-cognitive virtual reality (VR) intervention for gait rehabilitation and fall prevention, announced today the granting of a new Current Procedural Terminology (CPT®) Category III add-on code 0791T for its technology. The new CPT add-on code is used in conjunction with CPT code 97116 (Gait Training) and will become effective on July 1, 2023. Healthcare providers can submit claims with the new code when they perform a 15-minute gait training session in conjunction with the FDA-listed GaitBetter system. Any clinic providing and any patient requiring gait training will benefit immensely from this new CPT code. This includes, but not limited to, patients with total knee replacement that experience gait impairment, post-acute or chronic neurological patients struggling with motor-cognitive function, or older adults with a history of falls.

Key Points: 
  • ROCKVILLE, Md., Feb. 2, 2023 /PRNewswire-PRWeb/ -- GaitBetter , a digital neurotherapeutics company providing a state-of-the-art motor-cognitive virtual reality (VR) intervention for gait rehabilitation and fall prevention, announced today the granting of a new Current Procedural Terminology (CPT®) Category III add-on code 0791T for its technology.
  • The new CPT add-on code is used in conjunction with CPT code 97116 (Gait Training) and will become effective on July 1, 2023.
  • Healthcare providers can submit claims with the new code when they perform a 15-minute gait training session in conjunction with the FDA-listed GaitBetter system.
  • Any clinic providing and any patient requiring gait training will benefit immensely from this new CPT code.

Collagen Supplement Global Market Report 2022: Rising Awareness of Health Benefits Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Monday, January 9, 2023

The global collagen supplement market size reached US$ 2.06 Billion in 2021.

Key Points: 
  • The global collagen supplement market size reached US$ 2.06 Billion in 2021.
  • Besides this, the rising awareness among the masses about the benefits of collagen supplements to prevent collagen deficiency in the body is contributing to the growth of the market.
  • This, along with the growing utilization of collagen supplements in the food and beverage (F&B) industry, is offering a positive market outlook.
  • The publisher provides an analysis of the key trends in each sub-segment of the global collagen supplement market report, along with forecasts at the global, regional and country level from 2022-2027.

QuidelOrtho and Runda Medical Form Joint Venture to Develop and Manufacture Assays for VITROS® Platform

Retrieved on: 
Friday, December 16, 2022

Runda Medical is a leading IVD distributor in China and has developed its own family of instruments and assays.

Key Points: 
  • Runda Medical is a leading IVD distributor in China and has developed its own family of instruments and assays.
  • The JV will leverage both parties know-how in a range of incremental assays to broaden the VITROS test menu and gain efficiencies from local manufacturing at Runda Medicals Shanghai facility.
  • Both companies will contribute personnel and expertise to the joint venture and will share in the profits of the jointly developed products.
  • Currently, Runda Medical has more than 50 holding subsidiaries, providing integrated laboratory services to more than 4,000 public medical institutions in China.